摘要 |
There are disclosed 1-methyl-4,5-dihydroorotyl-histidylprolinamide or a pharmaceutically acceptable acid addition salt thereof, processes for their preparation and pharmaceutical compositions containing them. The prolinamide and the pharmaceutically acceptable acid addition salts thereof are useful for the treatment of central nervous system disorder. |